Skip to main content

CORRECTION article

Front. Immunol., 05 January 2024
Sec. Microbial Immunology
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1329317

Corrigendum: Serum IgG antibodies from pregnant women reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein

This article is a correction to:

  1. Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein

    1. Read original article
Elisa MazzoniElisa Mazzoni1Mariantonietta Di StefanoMariantonietta Di Stefano2Jos R. FioreJosè R. Fiore2Federica DestroFederica Destro1Marco ManfriniMarco Manfrini1John Charles RotondoJohn Charles Rotondo1Maria V. CasaliMaria V. Casali3Fortunato VesceFortunato Vesce4Pantaleo GrecoPantaleo Greco4Gennaro ScutieroGennaro Scutiero4Fernanda Martini*Fernanda Martini1*Mauro G. Tognon*Mauro G. Tognon1*
  • 1Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratories of Cell Biology and Molecular Genetics, University of Ferrara, Ferrara, Italy
  • 2Department of Clinical and Experimental Medicine, Clinic of Infectious Diseases, School of Medicine, University of Foggia, Foggia, Italy
  • 3Hospital Headquarter Department, State Hospital, Institute for Social Security, Borgo Maggiore, San Marino
  • 4Department of Morphology, Surgery and Experimental Medicine, Section of Obstetrics and Gynecology, University of Ferrara, Ferrara, Italy

A Corrigendum on
Serum IgG antibodies from pregnant women reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein

by Mazzoni E, Di Stefano M, Fiore JR, Destro F, Manfrini M, Rotondo JC, Casali MV, Vesce F, Greco P, Scutiero G, Martini F and Tognon MG (2017) Front. Immunol. 8:411. doi: 10.3389/fimmu.2017.00411

In the published article, there was an error in Figure 2 as published. Some technical problems may have occurred regarding the Figures 2C, D panels. There was an overlapping of two photographs taken at the same time, causing a partial duplication of the same field. The corrected Figure 2 and its caption appear below.

Figure 2
www.frontiersin.org

Figure 2 Inhibition of Simian virus 40 (SV40) cytopathic effect (CPE) in CV-1 infected cells by human immune sera. Inhibition of SV40 CPE in infected cells by human serum samples from pregnant women and non-pregnant women. Upper panel. (A) Negative control represented by uninfected CV-1 cells. (B) Positive control represented by the CPE induced by SV40 in CV-1 infected cells. (C, D) These sera did not inhibit SV40 CPE. (E–G) SV40-positive sera inhibited SV40 CPE with different degrees. (H) This serum sample completely inhibited SV40 CPE. Sample H had an optical density (OD) of 0.876 for the LT mimotopes. Bottom panel: there was a correlation between the OD values and CPE inhibition activity of tested immune sera. Indeed, serum samples C and D that were under the cutoff value did not inhibited SV40 CPE, while sera E, F, and G with an OD in the range of 0.193–0.643 inhibited partially with a different degree SV40 CPE. The serum in H panel, with the higher OD value, inhibited completely SV40 CPE.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pregnancy, polyomavirus, Simian virus 40, infection, antibody, seroprevalence, oncogene, ELISA

Citation: Mazzoni E, Di Stefano M, Fiore JR, Destro F, Manfrini M, Rotondo JC, Casali MV, Vesce F, Greco P, Scutiero G, Martini F and Tognon MG (2024) Corrigendum: Serum IgG antibodies from pregnant women reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein. Front. Immunol. 14:1329317. doi: 10.3389/fimmu.2023.1329317

Received: 28 October 2023; Accepted: 07 November 2023;
Published: 05 January 2024.

Edited and Reviewed by:

Ian Marriott, University of North Carolina at Charlotte, United States

Copyright © 2024 Mazzoni, Di Stefano, Fiore, Destro, Manfrini, Rotondo, Casali, Vesce, Greco, Scutiero, Martini and Tognon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fernanda Martini, bXJmQHVuaWZlLml0; Mauro G. Tognon, dGdtQHVuaWZlLml0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.